Annual Accounts Receivable
$973.90 M
+$260.60 M+36.53%
31 December 2023
Summary:
DexCom annual accounts receivable is currently $973.90 million, with the most recent change of +$260.60 million (+36.53%) on 31 December 2023. During the last 3 years, it has risen by +$545.40 million (+127.28%). DXCM annual accounts receivable is now at all-time high.DXCM Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$1.00 B
+$56.80 M+6.01%
30 September 2024
Summary:
DexCom quarterly accounts receivable is currently $1.00 billion, with the most recent change of +$56.80 million (+6.01%) on 30 September 2024. Over the past year, it has increased by +$216.30 million (+27.53%). DXCM quarterly accounts receivable is now at all-time high.DXCM Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.5% | +27.5% |
| 3 y3 years | +127.3% | +89.4% |
| 5 y5 years | +329.6% | +326.6% |
DXCM Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +127.3% | at high | +94.8% |
| 5 y | 5 years | at high | +329.6% | at high | +326.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
DexCom Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.00 B(+6.0%) |
| June 2024 | - | $945.20 M(-3.4%) |
| Mar 2024 | - | $978.60 M(+0.5%) |
| Dec 2023 | $973.90 M(+36.5%) | $973.90 M(+24.0%) |
| Sept 2023 | - | $785.70 M(+4.7%) |
| June 2023 | - | $750.60 M(+17.9%) |
| Mar 2023 | - | $636.80 M(-10.7%) |
| Dec 2022 | $713.30 M(+38.7%) | $713.30 M(+26.4%) |
| Sept 2022 | - | $564.10 M(+0.6%) |
| June 2022 | - | $560.80 M(+3.0%) |
| Mar 2022 | - | $544.50 M(+5.9%) |
| Dec 2021 | $514.30 M(+20.0%) | $514.30 M(-2.8%) |
| Sept 2021 | - | $529.10 M(+9.4%) |
| June 2021 | - | $483.50 M(+9.0%) |
| Mar 2021 | - | $443.40 M(+3.5%) |
| Dec 2020 | $428.50 M(+49.7%) | $428.50 M(+15.8%) |
| Sept 2020 | - | $370.00 M(+24.8%) |
| June 2020 | - | $296.50 M(-1.4%) |
| Mar 2020 | - | $300.70 M(+5.0%) |
| Dec 2019 | $286.30 M(+26.3%) | $286.30 M(+21.9%) |
| Sept 2019 | - | $234.90 M(+8.1%) |
| June 2019 | - | $217.30 M(+6.2%) |
| Mar 2019 | - | $204.70 M(-9.7%) |
| Dec 2018 | $226.70 M(+68.8%) | $226.70 M(+33.5%) |
| Sept 2018 | - | $169.80 M(+4.8%) |
| June 2018 | - | $162.00 M(+30.8%) |
| Mar 2018 | - | $123.90 M(-7.7%) |
| Dec 2017 | $134.30 M(+32.1%) | $134.30 M(+21.5%) |
| Sept 2017 | - | $110.50 M(+8.7%) |
| June 2017 | - | $101.70 M(+18.4%) |
| Mar 2017 | - | $85.90 M(-15.5%) |
| Dec 2016 | $101.70 M(+37.2%) | $101.70 M(+32.4%) |
| Sept 2016 | - | $76.80 M(+4.1%) |
| June 2016 | - | $73.80 M(+9.7%) |
| Mar 2016 | - | $67.30 M(-9.2%) |
| Dec 2015 | $74.10 M | $74.10 M(+32.8%) |
| Sept 2015 | - | $55.80 M(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $45.50 M(+13.2%) |
| Mar 2015 | - | $40.20 M(-5.2%) |
| Dec 2014 | $42.40 M(+62.5%) | $42.40 M(+35.0%) |
| Sept 2014 | - | $31.40 M(+9.8%) |
| June 2014 | - | $28.60 M(+20.2%) |
| Mar 2014 | - | $23.80 M(-8.8%) |
| Dec 2013 | $26.10 M(+33.8%) | $26.10 M(+20.8%) |
| Sept 2013 | - | $21.60 M(+22.0%) |
| June 2013 | - | $17.70 M(+8.6%) |
| Mar 2013 | - | $16.30 M(-16.4%) |
| Dec 2012 | $19.50 M(+56.0%) | $19.50 M(+57.8%) |
| Sept 2012 | - | $12.36 M(-4.2%) |
| June 2012 | - | $12.90 M(+2.8%) |
| Mar 2012 | - | $12.54 M(+0.3%) |
| Dec 2011 | $12.50 M(+87.4%) | $12.50 M(+38.8%) |
| Sept 2011 | - | $9.00 M(+3.6%) |
| June 2011 | - | $8.69 M(+21.5%) |
| Mar 2011 | - | $7.16 M(+7.3%) |
| Dec 2010 | $6.67 M(+91.1%) | $6.67 M(+30.8%) |
| Sept 2010 | - | $5.10 M(+9.5%) |
| June 2010 | - | $4.66 M(+22.6%) |
| Mar 2010 | - | $3.80 M(+8.9%) |
| Dec 2009 | $3.49 M(+212.2%) | $3.49 M(+40.3%) |
| Sept 2009 | - | $2.49 M(+20.3%) |
| June 2009 | - | $2.07 M(+53.7%) |
| Mar 2009 | - | $1.34 M(+20.3%) |
| Dec 2008 | $1.12 M(+420.0%) | $1.12 M(+160.6%) |
| Sept 2008 | - | $429.00 K(-24.5%) |
| June 2008 | - | $568.00 K(+76.9%) |
| Mar 2008 | - | $321.00 K(+49.3%) |
| Dec 2007 | $215.00 K(+79.2%) | $215.00 K(+25.7%) |
| Sept 2007 | - | $171.00 K(+35.7%) |
| June 2007 | - | $126.00 K(-36.4%) |
| Mar 2007 | - | $198.00 K(+65.0%) |
| Dec 2006 | $120.00 K | $120.00 K(+0.7%) |
| Sept 2006 | - | $119.20 K(+30.4%) |
| June 2006 | - | $91.40 K |
FAQ
- What is DexCom annual accounts receivable?
- What is the all time high annual accounts receivable for DexCom?
- What is DexCom annual accounts receivable year-on-year change?
- What is DexCom quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for DexCom?
- What is DexCom quarterly accounts receivable year-on-year change?
What is DexCom annual accounts receivable?
The current annual accounts receivable of DXCM is $973.90 M
What is the all time high annual accounts receivable for DexCom?
DexCom all-time high annual accounts receivable is $973.90 M
What is DexCom annual accounts receivable year-on-year change?
Over the past year, DXCM annual accounts receivable has changed by +$260.60 M (+36.53%)
What is DexCom quarterly accounts receivable?
The current quarterly accounts receivable of DXCM is $1.00 B
What is the all time high quarterly accounts receivable for DexCom?
DexCom all-time high quarterly accounts receivable is $1.00 B
What is DexCom quarterly accounts receivable year-on-year change?
Over the past year, DXCM quarterly accounts receivable has changed by +$216.30 M (+27.53%)